Global CBD Nutraceuticals Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

CBD Nutraceuticals Market Size

• The global CBD nutraceuticals market size was valued at USD 11.90 billion in 2025 and is expected to reach USD 45.35 billion by 2033, at a CAGR of 18.20% during the forecast period
• The market growth is largely fueled by rising consumer preference for natural wellness solutions and the expanding acceptance of CBD-based supplements for stress relief, pain management, sleep support, and overall well-being across diverse age groups and lifestyles
• Furthermore, increasing product availability through retail stores, pharmacies, and online platforms is strengthening CBD nutraceutical accessibility, while clearer regulatory guidelines in several regions are boosting consumer confidence and encouraging brand expansion. These converging factors are accelerating the adoption of CBD nutraceuticals, thereby significantly supporting the market’s upward trajectory

CBD Nutraceuticals Market Analysis

• CBD nutraceuticals, encompassing tinctures, capsules, gummies, and topical formulations, are emerging as essential components of modern wellness routines due to their perceived therapeutic benefits and suitability for daily health management across consumer segments
• The escalating demand for CBD nutraceuticals is primarily fueled by the shift toward plant-based health products, rising awareness of CBD’s functional benefits, and the growing inclusion of CBD supplements within mainstream nutraceutical and health retail channels
• North America dominated the CBD nutraceuticals market with a share of 89.4% in 2025, due to rising consumer interest in natural wellness products and growing acceptance of CBD-based functional supplements across the region
• Asia-Pacific is expected to be the fastest growing region in the CBD nutraceuticals market during the forecast period due to expanding urban populations, rising disposable incomes, and evolving regulatory landscapes in countries such as Japan, China, and Australia
• CBD tinctures segment dominated the market with a market share of 41.7% in 2025, due to their high bioavailability, rapid absorption, and versatility in dosage, which make them preferred among consumers seeking fast-acting wellness support. Tinctures offer flexible consumption through sublingual use or food and beverage integration, resulting in strong adoption among both first-time and experienced CBD users. Their ease of formulation customization, such as varying strengths and flavor profiles, also strengthens market share, especially as brands expand premium and organic tincture lines. Growing recommendation by wellness practitioners and increasing acceptance in daily health routines further reinforce the dominant position of tinctures in the product category

Report Scope and CBD Nutraceuticals Market Segmentation

CBD Nutraceuticals Market Trends

Rising Demand for Plant-Based Wellness Supplements

• A significant trend in the CBD nutraceuticals market is the rising demand for plant-based wellness supplements, driven by increasing consumer preference for natural ingredients that support stress relief, sleep enhancement, and daily well-being. This shift reflects a broader movement toward botanical-based health solutions as consumers seek clean-label, minimally processed products for long-term wellness management
  • For instance, leading companies such as CV Sciences and Garden of Life are expanding their CBD tinctures, gummies, and softgel lines that focus on natural formulations, reinforcing the appeal of plant-derived bioactive compounds. Such offerings strengthen consumer trust and support the transition toward holistic wellness routines that incorporate CBD-rich nutraceuticals
• The integration of CBD into functional formats such as gummies, capsules, and infused oils is expanding rapidly as brands cater to users seeking convenient and easily consumable wellness products. This adoption is positioning CBD nutraceuticals as essential components of modern lifestyle health categories where simplicity and natural efficacy are prioritized
• The market is witnessing strong demand from individuals seeking daily stress management and sleep support, with CBD delivering perceived benefits related to relaxation and balance. This trend is accelerating the development of specialized formulations that target mood, immune health, and cognitive performance
• Consumers are increasingly exploring CBD in combination with other botanicals such as adaptogens, vitamins, and herbal extracts to enhance the functional profile of nutraceuticals. This movement supports the creation of multi-benefit products that align with the growing preference for comprehensive wellness solutions
• The rising popularity of CBD nutraceuticals across retail stores, pharmacies, and e-commerce platforms is reinforcing market expansion as accessibility improves and consumer awareness deepens. These developments collectively strengthen the transition toward natural, plant-based supplementation and elevate CBD as a core element within the broader nutraceutical landscape

CBD Nutraceuticals Market Dynamics

Driver

Increasing Consumer Adoption of CBD for Stress and Sleep Support

• The increasing consumer adoption of CBD for stress reduction and improved sleep quality is driving the growth of the CBD nutraceuticals market, as individuals seek safer and plant-based alternatives to traditional relaxation or sleep aid products. CBD’s perceived calming properties resonate strongly with consumers seeking daily relief from anxiety, workload pressure, and sleep disturbances
  • For instance, brands such as Medterra offer CBD softgels and tinctures formulated specifically for relaxation and nighttime support, helping users incorporate CBD into their wellness routines with confidence. Such targeted formulations enhance product reliability and strengthen brand positioning within stress- and sleep-related supplement categories
• The growing prevalence of sleep disorders, heightened stress levels, and fast-paced lifestyles is encouraging the use of CBD nutraceuticals as part of daily self-care, especially among working professionals and older adults. This dynamic continues to elevate CBD’s relevance as a non-habit-forming wellness option
• Expanding distribution through pharmacies, specialty wellness stores, and online retail channels is improving product visibility and making stress- and sleep-focused CBD nutraceuticals more accessible. This sustained adoption is reinforcing market stability and broadening CBD’s presence in mainstream consumer health categories
• The continued shift toward mental wellness and preventive healthcare ensures steady demand for CBD supplements that offer relaxation, balance, and sleep enhancement. This driver remains central to the market’s upward momentum and long-term expansion

Restraint/Challenge

Regulatory Variability Across Countries

• The CBD nutraceuticals market faces a challenge due to significant regulatory variability across countries, with inconsistent policies governing the production, sale, and labeling of CBD-based supplements. These inconsistencies create uncertainty for manufacturers and limit the ability to scale operations globally
  • For instance, companies such as ENDOCA must navigate complex compliance requirements that vary widely across regions, influencing product formulation strategies and distribution planning. Ensuring adherence to evolving standards increases operational burdens and complicates market expansion
• The lack of uniform global standards for THC content, ingredient approval, and health claims restricts manufacturers’ flexibility and leads to delays in product launches across key markets. This regulatory fragmentation slows innovation and impacts companies seeking wider penetration
• Changing rules and periodic enforcement actions in certain regions create supply chain unpredictability, making long-term planning difficult for CBD nutraceutical brands. These conditions also affect pricing stability and product availability
• The ongoing challenge of harmonizing regulations across international boundaries continues to place pressure on manufacturers to adapt rapidly while balancing compliance and cost efficiency. This complexity remains a core restraint for sustained, large-scale CBD nutraceutical expansion

CBD Nutraceuticals Market Scope

The market is segmented on the basis of product type, sales channel, end-user, and formulation type.

• By Product Type

On the basis of product type, the CBD nutraceuticals market is segmented into CBD tinctures, capsules and soft gels, CBD gummies, and others. The CBD tinctures segment dominated the market with the largest share of 41.7% in 2025 due to their high bioavailability, rapid absorption, and versatility in dosage, which make them preferred among consumers seeking fast-acting wellness support. Tinctures offer flexible consumption through sublingual use or food and beverage integration, resulting in strong adoption among both first-time and experienced CBD users. Their ease of formulation customization, such as varying strengths and flavor profiles, also strengthens market share, especially as brands expand premium and organic tincture lines. Growing recommendation by wellness practitioners and increasing acceptance in daily health routines further reinforce the dominant position of tinctures in the product category.

The CBD gummies segment is expected to witness the fastest growth rate from 2026 to 2033, driven by rising consumer preference for convenient, flavorful, and discreet nutraceutical formats. Gummies offer a familiar, candy-like experience that appeals to younger consumers and wellness users who prefer taste-based delivery systems over oils or capsules. Their pre-measured dosage provides consistent intake, boosting adoption among individuals looking for controlled CBD consumption. Gummies also benefit from strong innovation in forms such as sugar-free, vegan, and functional blends targeting sleep, stress, and immunity, enabling brands to target broader wellness segments. Their increasing penetration across retail shelves and expansion in lifestyle-oriented marketing further propel segment growth.

• By Sales Channel

On the basis of sales channel, the CBD nutraceuticals market is segmented into retail stores, online, and pharmacies. The online segment dominated the market in 2025 due to its wide product availability, extensive brand variety, and the convenience of direct-to-consumer delivery models supporting CBD purchases. E-commerce platforms allow customers to compare potency, formulations, and third-party lab results, which increases consumer confidence in product quality. Subscription-based models, influencer-driven branding, and targeted digital advertising also contribute to strong online demand. The ease of access to user reviews and educational content further supports consumer decisions, strengthening the dominance of online sales in CBD nutraceutical distribution.

The pharmacy segment is expected to witness the fastest CAGR from 2026 to 2033, driven by rising regulatory clarity and increasing acceptance of CBD nutraceuticals within formal healthcare retail environments. Pharmacies provide credibility and professional assurance, which is essential for consumers seeking medically aligned wellness products. As more pharmacists receive training on CBD efficacy and safety, consumers gain trusted guidance on product selection and dosage. Pharmacies also expand shelf space for certified and clinically backed CBD formulations, encouraging adoption among older adults and individuals with chronic health concerns. Growing partnerships between CBD manufacturers and pharmacy chains further accelerate the segment’s projected growth.

CBD Nutraceuticals Market Regional Analysis

• North America dominated the CBD nutraceuticals market with the largest revenue share of 89.4% in 2025, driven by rising consumer interest in natural wellness products and growing acceptance of CBD-based functional supplements across the region
• Consumers increasingly prefer CBD formulations for stress relief, pain management, and overall well-being, supporting market growth
• This expanding adoption is strengthened by supportive regulatory developments, higher disposable incomes, and a strong presence of established nutraceutical brands, positioning CBD nutraceuticals as a mainstream wellness solution across retail and online channels

U.S. CBD Nutraceuticals Market Insight

The U.S. CBD nutraceuticals market captured the largest revenue share within North America in 2025, fueled by heightened demand for plant-based health solutions and the expanding retail availability of CBD products. Consumers are prioritizing CBD tinctures, gummies, and capsules as part of their daily wellness routines, resulting in accelerated product adoption. The presence of a mature health supplement industry, combined with the rise in e-commerce penetration and continuous introduction of new CBD formulations, is further strengthening the country's market expansion.

Europe CBD Nutraceuticals Market Insight

The Europe CBD nutraceuticals market is projected to expand at a substantial CAGR throughout the forecast period due to increasing regulatory clarity, broader acceptance of hemp-derived supplements, and a rising focus on preventive health. Growing consumer awareness regarding the benefits of CBD for relaxation, sleep improvement, and immune support is boosting demand. The region is experiencing accelerated market penetration across pharmacies, specialty stores, and online platforms, with both established nutraceutical companies and new entrants strengthening their foothold.

U.K. CBD Nutraceuticals Market Insight

The U.K. CBD nutraceuticals market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by a strong regulatory framework and rising consumer interest in natural supplements. Growing awareness of CBD’s wellness benefits and the availability of certified, high-quality products are encouraging adoption. The U.K.’s robust e-commerce ecosystem and increasing presence of CBD brands across retail chains are supporting sustained market development.

Germany CBD Nutraceuticals Market Insight

The Germany CBD nutraceuticals market is expected to expand at a considerable CAGR during the forecast period, supported by rising emphasis on health-conscious living and demand for scientifically validated wellness products. Germany’s strong regulatory standards, along with consumer preference for premium-quality supplements, are encouraging the adoption of CBD nutraceuticals. The market is also benefiting from the increasing presence of pharmacy-based CBD offerings and a growing shift toward natural therapeutic alternatives.

Asia-Pacific CBD Nutraceuticals Market Insight

The Asia-Pacific CBD nutraceuticals market is poised to grow at the fastest CAGR during the forecast period, driven by expanding urban populations, rising disposable incomes, and evolving regulatory landscapes in countries such as Japan, China, and Australia. Growing consumer acceptance of CBD-based supplements for stress reduction, sleep enhancement, and general wellness is fueling rapid market expansion. The region’s growing e-commerce market and increasing presence of international CBD brands are further accelerating adoption.

Japan CBD Nutraceuticals Market Insight

The Japan CBD nutraceuticals market is gaining momentum due to the rising popularity of functional wellness products and the country’s preference for high-quality, science-backed supplements. Japanese consumers are increasingly adopting CBD products for calmness, sleep improvement, and daily balance. The growth is further strengthened by rapid urbanization, expanding retail availability, and the introduction of premium CBD formulations tailored to local consumer expectations.

China CBD Nutraceuticals Market Insight

The China CBD nutraceuticals market accounted for the largest revenue share in Asia-Pacific in 2025, supported by the country’s large consumer base and growing acceptance of hemp-derived supplements. Rising awareness of CBD’s wellness benefits, combined with strong domestic manufacturing capabilities, is accelerating market penetration. The expansion of online retail channels, growing middle-class consumption, and increasing demand for natural health products are key factors propelling the CBD nutraceuticals market across China.

CBD Nutraceuticals Market Share

The CBD nutraceuticals industry is primarily led by well-established companies, including:

• Gaia Botanicals, LLC (U.S.)
• CV Sciences, Inc. (U.S.)
• Elixinol LLC (U.S.)
• ENDOCA (Netherlands)
• Garden of Life (U.S.)
• Green Roads (U.S.)
• Isodiol International Inc. (Canada)
• Medical Marijuana, Inc. (U.S.)
• Medterra (U.S.)
• NuLeaf Naturals, LLC (U.S.)
• Joy Organics (U.S.)
• Diamond CBD (U.S.)
• CBDistillery (U.S.)
• GVB Biopharma (U.S.)

Latest Developments in Global CBD Nutraceuticals Market

• In October 2025, CBD Life Sciences Inc. (CBDL) launched a new line of hemp-free, vegan gummies — branded as Energy-Boost and Diet & Weight-Loss gummies — to tap into the growing demand for performance nutrition and wellness supplements beyond traditional CBD products. With this move, CBDL is positioning itself at the intersection of fitness, nutrition, and wellness: the new SKUs broaden its consumer base to individuals seeking energy, metabolism support, or weight management rather than just CBD-based relaxation or wellness
• In September 2024, Charlotte’s Web Holdings, Inc. expanded its CBD nutraceuticals portfolio by launching new soft-gel capsules and a series of functional mushroom-infused gummies designed for stress support, energy enhancement, and cognitive wellness. This expansion strengthens the company’s position in multifunctional wellness products and broadens consumer reach by combining CBD with trending adaptogenic ingredients, reinforcing its leadership in the premium nutraceuticals category
• In June 2024, Rodedawg International Industries, Inc. introduced its Nutrient CBD line consisting of five diversified SKUs, including CBD oil tinctures, topical creams, and a roll-on solution to address expanding wellness needs across pain relief, relaxation, and skin support. This launch enhances the company’s competitive presence in the CBD nutraceuticals space and supports growing consumer demand for versatile, natural wellness alternatives
• In May 2024, CV Sciences Inc. acquired Elevated Softgels LLC, a prominent manufacturer specializing in encapsulated softgels and tincture formulations, enabling CV Sciences to significantly expand its production capabilities and global reach. This acquisition strengthens the company’s foothold in the CBD nutraceuticals market by enhancing formulation expertise, manufacturing scale, and product innovation potential
• In March 2024, Hempacco Co., Inc. strengthened its manufacturing footprint by acquiring key assets of Covalent CBD, a well-known white-label nutraceutical producer specializing in hemp-derived supplements. This strategic move increases Hempacco’s capacity to supply a broader range of private-label CBD nutraceuticals and accelerates its expansion into functional wellness categories, improving its ability to meet rising B2B demand

SKU-61391